3, 4-Disubstituted isothiazoles: novel potent inhibitors of VEGF receptors 1 and 2

AS Kiselyov, M Semenova, VV Semenov

Index: Kiselyov, Alexander S.; Semenova, Marina; Semenov, Victor V. Bioorganic and Medicinal Chemistry Letters, 2009 , vol. 19, # 4 p. 1195 - 1198

Full Text: HTML

Citation Number: 19

Abstract

Novel derivatives of isothiazoles are described as potent ATP-competitive inhibitors of vascular endothelial growth factor receptors I and II (VEGFR-1/2). A number of compounds exhibited VEGFR-2 inhibitory activity comparable to that of Vatalanib™ in both HTRF enzymatic and cellular assays. Several derivatives featuring bulky meta-substituents in the amide portion of the molecule displayed 4-to 8-fold specificity for VEGFR-2 versus VEGFR ...

Related Articles:

Synthesis, structure-activity relationships, and pharmacokinetic properties of dihydroorotate dehydrogenase inhibitors: 2-cyano-3-cyclopropyl-3-hydroxy-N-[3'-methyl-4 …

[Kuo, Elizabeth A.; Hambleton, Philip T.; Kay, David P.; Evans, Phillip L.; Matharu, Saroop S.; Little, Edward; McDowall, Neil; Jones, C. Beth; Hedgecock, Charles J. R.; Yea, Christopher M.; Chan, A. W. Edith; Hairsine, Peter W.; Ager, Ian R.; Tully, W. Roger; Williamson, Richard A.; Westwood, Robert Journal of Medicinal Chemistry, 1996 , vol. 39, # 23 p. 4608 - 4621]

More Articles...